68
Participants
Start Date
October 19, 2018
Primary Completion Date
February 22, 2022
Study Completion Date
June 30, 2022
Ivabradine
"Ivabradine 5 mg, twice a day the first month administered by mouth. If the tolerance is good, the dose will be increased to 7.5 mg on month 2 and will continue until the third month.~Patients with 75 or more years of age will receive an initial dose of 2.5 mg / twice a day, which can be increased to 5 mg / twice a day in week 7 and to 7.5 mg in month 1 if the tolerance has been good"
Digoxin
The initial dose will be based on whether there are factors such as age over 80 years, weight less than 60 kg and creatinine clearance \<60ml / min, if there is no factor, the oral dose will be 0.25mg / 24h. If there are 2 factors, the dose will be 0.15 mg / 24 h. and if there are 2 or 3 factors, the dose will be 0.10 mg / 24 h.
Hospital Universitario Puerta de Hierro, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Fundación Jiménez Díaz, Madrid
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario de Getafe, Madrid
Hospital Universitario Rey Juan Carlos, Madrid
Hospital Virgen de la Salud, Toledo
Hospital Universitario de Burgos, Burgos
Spanish Clinical Research Network - SCReN
NETWORK
Carlos III Health Institute
OTHER_GOV
Adolfo Fontenla
OTHER